NAPO PHARMACEUTICALS INC

Profile

Company Names

NAPO PHARMACEUTICALS INC

Addresses

185 BERRY STREET, SUITE 1300, SAN FRANCISCO, CA 94107

250 E. GRAND AVENUE, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

415-371-8300
6506161900

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$10,081,869.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2014-03-18 
$137,500.00 
$137,500.00 
$0.00 
Debt 
4
2011-07-06 
$3,087,500.00 
$5,000,000.00 
$1,912,500.00 
Equity 
3
2011-02-17 
$2,996,869.00 
$6,000,000.00 
$3,003,131.00 
Equity, Debt 
2
2010-06-07 
$3,360,000.00 
$8,900,000.00 
$5,540,000.00 
Equity 
1
2009-05-12 
$500,000.00 
$500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PRAVI 
 
CHATURVEDI 
EXECUTIVE OFFICER
NAPO PHARMACEUTICALS INC
PRAVIN 
 
CHATURVEDI 
EXECUTIVE OFFICER
NAPO PHARMACEUTICALS INC   |  PIVOT PHARMACEUTICALS INC.   |  JAGUAR HEALTH, INC.
LISA 
 
CONTE 
EXECUTIVE OFFICER, DIRECTOR
NAPO PHARMACEUTICALS INC   |  JAGUAR ANIMAL HEALTH, INC.   |  JAGUAR HEALTH, INC.
DENNIS 
 
FENTON 
DIRECTOR
KYTHERA BIOPHARMACEUTICALS INC   |  NAPO PHARMACEUTICALS INC   |  GENELUX CORP   |  NORA THERAPEUTICS, INC.   |  SIENNA BIOPHARMACEUTICALS, INC.   |  MODERN MEADOW, INC.   |  PBS BIOTECH, INC.
RICHARD 
 
FIELDS 
DIRECTOR
SEMISUB INC   |  SELECTABLE MEDIA INC.   |  NAPO PHARMACEUTICALS INC   |  ORION LABS, INC.
STEVEN 
 
KING 
EXECUTIVE OFFICER
NAPO PHARMACEUTICALS INC   |  INNOTAS   |  JAGUAR ANIMAL HEALTH, INC.   |  JAGUAR HEALTH, INC.   |  VIRALCLEAR PHARMACEUTICALS, INC.
JOSHUA 
 
MAILMAN 
DIRECTOR
CATCHAFIRE, INC.   |  ALTER ECO AMERICAS, INC.   |  GENERAL COMPRESSION, INC.   |  HOWGOOD, INC.   |  NAPO PHARMACEUTICALS INC   |  DRAGON SPAC S.P.A.
GREGORY 
 
STOCK 
DIRECTOR
NAPO PHARMACEUTICALS INC   |  SIGNUM BIOSCIENCES, INC.   |  STOCK PRODUCTIONS LLC   |  SOCRATIC SCIENCES, INC.
CHARLES 
 
THOMPSON 
EXECUTIVE OFFICER
COBALT FUND LP   |  NAPO PHARMACEUTICALS INC   |  DIGITAL MANAGEMENT, INC.   |  BLACK BEAR FOREST INC   |  JAGUAR ANIMAL HEALTH, INC.   |  EZ STORE, LLC   |  EVERGREEN AT RIVER OAKS INVESTORS, LP
THOMAS 
 
VAN DYCK 
DIRECTOR
NAPO PHARMACEUTICALS INC
JACK 
 
VAN HULST 
DIRECTOR
NAPO PHARMACEUTICALS INC   |  SENESCO TECHNOLOGIES INC
SIR WILLIAM 
 
YOUNG 
DIRECTOR
NAPO PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-06-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-03-18 
2011-10-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-06 
2011-06-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-02-17 
2010-10-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-07 
2009-07-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#